GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Sun Pharmaceutical Industries Ltd SUNPHARMA.NS · INR

Pharmaceuticals · NSE · 🇮🇳 India

Nifty 50

Compare

1,904.50

+2.39%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Sun Pharmaceutical Industries Ltd — daily BSE:SUNPHARMA End of day BSE listing — our prices are the NSE line

Why two exchanges. Sun Pharmaceutical Industries Ltd trades on both NSE and BSE. TradingView's free charts don't carry NSE, so the chart shows the BSE listing. The ticker and close we quote are the NSE line.

Market value
₹4.57trn
Last close × shares
Volume
3.3m
Shares, 9 Nov 2026
Price to earnings
38.0
Dividend yield
1.75%

About Sun Pharmaceutical Industries Ltd

Its shares trade on NSE under the ticker SUNPHARMA.NS. It has been listed since 1 January 1994. It is a member of the Nifty 50. In the fiscal year to 31 March 2026, it reported revenue of ₹582.20bn and net income of ₹114.79bn. At that date it held total assets of ₹1.09trn and shareholders' equity of ₹835.70bn.

Sun Pharmaceutical Industries Ltd. engages in manufacturing, developing, and marketing of pharmaceuticals products. The company is headquartered in Mumbai, Maharashtra. The firm is engaged in the business of manufacturing, developing and marketing a range of generic formulations. The company produces a portfolio of generic and specialty medicines targeting a spectrum of chronic and acute treatments. The Company’s product portfolio includes generics, branded generics, specialty, over the counter (OTC)/consumer healthcare products, anti-retrovirals (ARVs), active pharmaceutical ingredients (APIs) and intermediates. Its OTC brands includes Faringosept , Revital, and Volini. The firm offers its products in variety of dosage forms, such as tablets, capsules, sprays, injectables, inhalers, ointments, creams and liquids. Its portfolio of specialty products, branded generics are available across 100 countries. The firm operates manufacturing sites across 6 continents.

Figures and description from our data supplier, not checked against the company's own report.

More about Sun Pharmaceutical Industries Ltd →

Latest on Sun Pharmaceutical Industries Ltd

Our reporting

Next results

4 Feb 2027

Due on 4 Feb 2027. Analysts expect earnings of 14.10 a share.

Other India listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Sun Pharmaceutical Industries Ltd's ticker?

Sun Pharmaceutical Industries Ltd trades as SUNPHARMA.NS on NSE, under ISIN INE044A01036.

What was Sun Pharmaceutical Industries Ltd's last closing price?

1,904.50 on 9 Nov 2026. The figure is in INR and is never converted.

When does Sun Pharmaceutical Industries Ltd next report results?

Results are expected on 4 Feb 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.